{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:08:56Z","timestamp":1779080936098,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04681-0","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T23:35:12Z","timestamp":1776036912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Remote Self-help cognitive-behavioural Therapy for irritable bowel syndrome (ReSeT): protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Shino","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hissei","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Akechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"7","key":"4681_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712-21.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10263","key":"4681_CR2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","volume":"396","author":"CJ Black","year":"2020","unstructured":"Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2020;396(10263):1664\u201374.","journal-title":"Lancet"},{"issue":"8","key":"4681_CR3","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1038\/ajg.2009.232","volume":"104","author":"B Spiegel","year":"2009","unstructured":"Spiegel B, Harris L, Lucak S, Mayer E, Naliboff B, Bolus R, et al. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF cohort. Am J Gastroenterol. 2009;104(8):1984\u201391.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"4681_CR4","first-page":"755","volume":"19","author":"D Nellesen","year":"2013","unstructured":"Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm. 2013;19(9):755\u201364.","journal-title":"J Manag Care Pharm"},{"issue":"8","key":"4681_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","volume":"17","author":"CJ Black","year":"2020","unstructured":"Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473\u201386.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"4681_CR6","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41395-018-0262-x","volume":"113","author":"\u00c5 Fr\u00e4ndemark","year":"2018","unstructured":"Fr\u00e4ndemark \u00c5, T\u00f6rnblom H, Jakobsson S, Simr\u00e9n M. Work productivity and activity impairment in irritable bowel syndrome (IBS): a multifaceted problem. Am J Gastroenterol. 2018;113(10):1540\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"4681_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/apt.17132","volume":"56","author":"VC Goodoory","year":"2022","unstructured":"Goodoory VC, Ng CE, Black CJ, Ford AC. Impact of Rome IV irritable bowel syndrome on work and activities of daily living. Aliment Pharmacol Ther. 2022;56(5):844\u201356.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"4681_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","volume":"5","author":"P Oka","year":"2020","unstructured":"Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908\u201317.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"4681_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/MCG.0b013e318189a7f9","volume":"43","author":"DA Drossman","year":"2009","unstructured":"Drossman DA, Morris CB, Schneck S, Hu YJ, Norton NJ, Norton WF, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43(6):541\u201350.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"4681_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","volume":"116","author":"BE Lacy","year":"2021","unstructured":"Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG Clinical Guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17\u201344.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4681_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00535-020-01746-z","volume":"56","author":"S Fukudo","year":"2021","unstructured":"Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol. 2021;56(3):193\u2013217.","journal-title":"J Gastroenterol"},{"issue":"6-7","key":"4681_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.brat.2011.04.001","volume":"49","author":"MG Craske","year":"2011","unstructured":"Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49(6\u20137):413\u201321.","journal-title":"Behav Res Ther"},{"issue":"4","key":"4681_CR13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.14309\/ajg.0000000000001664","volume":"117","author":"S Kikuchi","year":"2022","unstructured":"Kikuchi S, Oe Y, Ito Y, Sozu T, Sasaki Y, Sakata M, et al. Group cognitive-behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2022;117(4):668\u201377.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"4681_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2468-1253(19)30291-2","volume":"4","author":"TH Taft","year":"2019","unstructured":"Taft TH. Improving access to gut\u2013brain therapies for IBS. Lancet Gastroenterol Hepatol. 2019;4(11):816\u20138.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"4681_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1001\/jamapsychiatry.2019.0268","volume":"76","author":"P Cuijpers","year":"2019","unstructured":"Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression. JAMA Psychiatr. 2019;76(7):700.","journal-title":"JAMA Psychiatr"},{"issue":"4","key":"4681_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jamapsychiatry.2020.4364","volume":"78","author":"E Karyotaki","year":"2021","unstructured":"Karyotaki E, Efthimiou O, Miguel C, Bermpohl FMG, Furukawa TA, Cuijpers P, et al. Internet-based cognitive behavioral therapy for depression: a systematic review and individual patient data network meta-analysis. JAMA Psychiat. 2021;78(4):361\u201371.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"4681_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41746-022-00702-w","volume":"5","author":"F K\u00e4hlke","year":"2022","unstructured":"K\u00e4hlke F, Buntrock C, Smit F, Ebert DD. Systematic review of economic evaluations for internet- and mobile-based interventions for mental health problems. NPJ Digit Med. 2022;5(1):175.","journal-title":"NPJ Digit Med"},{"issue":"8","key":"4681_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/1357633X17717402","volume":"24","author":"DM Sztein","year":"2018","unstructured":"Sztein DM, Koransky CE, Fegan L, Himelhoch S. Efficacy of cognitive behavioural therapy delivered over the Internet for depressive symptoms: a systematic review and meta-analysis. J Telemed Telecare. 2018;24(8):527\u201339.","journal-title":"J Telemed Telecare"},{"issue":"8","key":"4681_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","volume":"69","author":"CJ Black","year":"2020","unstructured":"Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69(8):1441\u201351.","journal-title":"Gut"},{"issue":"9","key":"4681_CR20","first-page":"1613","volume":"68","author":"HA Everitt","year":"2019","unstructured":"Everitt HA, Landau S, O\u2019Reilly G, Sibelli A, Hughes S, Windgassen S, et al. Assessing telephone-delivered cognitive\u2013behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut. 2019;68(9):1613\u201323.","journal-title":"GUT"},{"issue":"8","key":"4681_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/ajg.2011.139","volume":"106","author":"B Lj\u00f3tsson","year":"2011","unstructured":"Lj\u00f3tsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial. Am J Gastroenterol. 2011;106(8):1481\u201391.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"4681_CR22","doi-asserted-by":"publisher","first-page":"e35260","DOI":"10.2196\/35260","volume":"24","author":"H Kim","year":"2022","unstructured":"Kim H, Oh Y, Chang SJ. Internet-delivered cognitive behavioral therapy in patients with irritable bowel syndrome: systematic review and meta-analysis. J Med Internet Res. 2022;24(6):e35260.","journal-title":"J Med Internet Res"},{"issue":"9","key":"4681_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/1755738012471029","volume":"6","author":"K Fenn","year":"2013","unstructured":"Fenn K, Byrne M. The key principles of cognitive behavioural therapy. InnovAiT: Education and inspiration for general practice. 2013;6(9):579\u201385.","journal-title":"InnovAiT: Education and inspiration for general practice"},{"key":"4681_CR24","unstructured":"Padesky CA. Socratic questioning: changing minds or guiding discovery? London: Invited keynote address presented at the European Congress of Behavioural and Cognitive Therapies; 1993. Available from: https:\/\/www.scribd.com\/document\/331038117\/socquest-pdf."},{"issue":"3","key":"4681_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/1097-4679(198007)36:3<696::AID-JCLP2270360315>3.0.CO;2-9","volume":"36","author":"M Sherer","year":"1980","unstructured":"Sherer M, Rogers RW. Effects of therapists nonverbal communication on rated skill and effectiveness. J Clin Psychol. 1980;36(3):696\u2013700.","journal-title":"J Clin Psychol"},{"key":"4681_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/13642537.2010.516064","volume":"12","author":"T Strong","year":"2010","unstructured":"Strong T. Staying in dialogue with CBT. Eur J Psychother Counsell. 2010;12:243\u201356.","journal-title":"Eur J Psychother Counsell"},{"key":"4681_CR27","first-page":"94","volume-title":"Handbook of psychotherapy integration","author":"MJ Lambert","year":"1992","unstructured":"Lambert MJ. Psychotherapy outcome research: Implications for integrative and eclectical therapists. Handbook of psychotherapy integration. New York, NY, US: Basic Books; 1992. p. 94\u2013129."},{"key":"4681_CR28","unstructured":"Guidelines for the practice of telepsychology 3 August 2023. Available from: https:\/\/www.apa.org\/practice\/guidelines\/telepsychology."},{"issue":"6","key":"4681_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jclp.22954","volume":"76","author":"C McCord","year":"2020","unstructured":"McCord C, Bernhard P, Walsh M, Rosner C, Console K. A consolidated model for telepsychology practice. J Clin Psychol. 2020;76(6):1060\u201382.","journal-title":"J Clin Psychol"},{"key":"4681_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/936960","volume":"2012","author":"S Evangelista","year":"2012","unstructured":"Evangelista S. Benefits from long-term treatment in irritable bowel syndrome. Gastroenterol Res Pract. 2012;2012:1\u20136.","journal-title":"Gastroenterol Res Pract"},{"issue":"23","key":"4681_CR31","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/jama.2022.21243","volume":"328","author":"NJ Butcher","year":"2022","unstructured":"Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial protocols: The SPIRIT-outcomes 2022 extension. JAMA. 2022;328(23):2345\u201356.","journal-title":"JAMA"},{"issue":"1","key":"4681_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","volume":"167","author":"I Boutron","year":"2017","unstructured":"Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40\u20137.","journal-title":"Ann Intern Med"},{"issue":"2","key":"4681_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395\u2013402.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"4681_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00535-006-1799-9","volume":"41","author":"M Shinozaki","year":"2006","unstructured":"Shinozaki M, Kanazawa M, Sagami Y, Endo Y, Hongo M, Drossman DA, et al. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol. 2006;41(5):491\u20134.","journal-title":"J Gastroenterol"},{"key":"4681_CR35","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","author":"F Mearin","year":"2016","unstructured":"MearinF, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders. Gastroenterology. 2016. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","journal-title":"Gastroenterology"},{"key":"4681_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brat.2014.04.006","volume":"58","author":"MG Craske","year":"2014","unstructured":"Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10\u201323.","journal-title":"Behav Res Ther"},{"issue":"5","key":"4681_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","volume":"319","author":"M Calvert","year":"2018","unstructured":"Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO Extension. JAMA. 2018;319(5):483\u201394.","journal-title":"JAMA"},{"issue":"4","key":"4681_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cgh.2017.12.026","volume":"16","author":"CV Almario","year":"2018","unstructured":"Almario CV, Spiegel BMR. Employing irritable bowel syndrome patient-reported outcomes in the clinical trenches. Clin Gastroenterol Hepatol. 2018;16(4):462-6.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4681_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1572-0241.2000.01941.x","volume":"95","author":"DA Drossman","year":"2000","unstructured":"Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95(4):999\u20131007.","journal-title":"Am J Gastroenterol"},{"key":"4681_CR40","unstructured":"ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med. 1999;18(15):1905\u201342."},{"key":"4681_CR41","doi-asserted-by":"publisher","unstructured":"Takashi Sozu TS, Toshimitsu Hamasaki, Scott R. Evans. Sample Size Determination in Clinical Trials with Multiple Endpoints Springer: Heidelberg; 2015. https:\/\/doi.org\/10.1007\/978-3-319-22005-5.","DOI":"10.1007\/978-3-319-22005-5"},{"issue":"2","key":"4681_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1023\/A:1018831127942","volume":"43","author":"DL Patrick","year":"1998","unstructured":"Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43(2):400\u201311.","journal-title":"Dig Dis Sci"},{"key":"4681_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1751-0759-1-6","volume":"1","author":"M Kanazawa","year":"2007","unstructured":"Kanazawa M, Drossman DA, Shinozaki M, Sagami Y, Endo Y, Palsson OS, et al. Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med. 2007;1:6.","journal-title":"Biopsychosoc Med"},{"issue":"1","key":"4681_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2036.2004.02007.x","volume":"20","author":"JS Labus","year":"2004","unstructured":"Labus JS, Bolus R, Chang L, Wiklund I, Naesdal J, Mayer EA, et al. The visceral sensitivity index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20(1):89\u201397.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4681_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/PSY.0b013e31802e2f24","volume":"69","author":"JS Labus","year":"2007","unstructured":"Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med. 2007;69(1):89\u201398.","journal-title":"Psychosom Med"},{"issue":"1","key":"4681_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1751-0759-8-10","volume":"8","author":"T Saigo","year":"2014","unstructured":"Saigo T, Tayama J, Hamaguchi T, Nakaya N, Tomiie T, Bernick PJ, et al. Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students. Biopsychosoc Med. 2014;8(1):10.","journal-title":"Biopsychosoc Med"},{"issue":"6","key":"4681_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond ASS, R. P. . The Hospital Anxiety and Depression Scale. . Acta Psychiatrica Scandinavica. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"4681_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53\u201372.","journal-title":"Health Policy"},{"issue":"5","key":"4681_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353\u201365.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"4681_CR50","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"4681_CR51","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.14309\/ajg.0000000000001942","volume":"117","author":"E Nordin","year":"2022","unstructured":"Nordin E, Hellstr\u00f6m PM, Brunius C, Landberg R. Modest conformity between self-reporting of Bristol stool form and fecal consistency measured by stool water content in irritable bowel syndrome and a FODMAP and gluten trial. Am J Gastroenterol. 2022;117(10):1668\u201374.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"4681_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","volume":"31","author":"GJ Devilly","year":"2000","unstructured":"Devilly GJ, Borkovec TD. Psychometric properties of the credibility\/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73\u201386.","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"7","key":"4681_CR53","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1023\/A:1024159226274","volume":"48","author":"S Gordon","year":"2003","unstructured":"Gordon S, Ameen V, Bagby B, Shahan B, Jhingran P, Carter E. Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci. 2003;48(7):1317\u201323.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"4681_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0149-7189(82)90074-X","volume":"5","author":"CC Attkisson","year":"1982","unstructured":"Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233\u20137.","journal-title":"Eval Program Plann"},{"issue":"5","key":"4681_CR55","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/aje\/kwx344","volume":"187","author":"J Savovic","year":"2018","unstructured":"Savovic J, Turner RM, Mawdsley D, Jones HE, Beynon R, Higgins JPT, et al. Association between risk-of-bias assessments and results of randomized trials in cochrane reviews: The ROBES meta-epidemiologic study. Am J Epidemiol. 2018;187(5):1113\u201322.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"4681_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S2215-0366(17)30153-0","volume":"4","author":"SM Gold","year":"2017","unstructured":"Gold SM, Enck P, Hasselmann H, Friede T, Hegerl U, Mohr DC, et al. Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry. 2017;4(9):725\u201332.","journal-title":"Lancet Psychiatry"},{"key":"4681_CR57","doi-asserted-by":"publisher","first-page":"e072108","DOI":"10.1136\/bmj-2022-072108","volume":"381","author":"D Hohenschurz-Schmidt","year":"2023","unstructured":"Hohenschurz-Schmidt D, Vase L, Scott W, Annoni M, Ajayi OK, Barth J, et al. Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS Statement. BMJ. 2023;381:e072108.","journal-title":"BMJ"},{"issue":"7501","key":"4681_CR58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.330.7501.1202","volume":"330","author":"C Paterson","year":"2005","unstructured":"Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ. 2005;330(7501):1202\u20135.","journal-title":"BMJ"},{"issue":"2","key":"4681_CR59","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1371\/journal.pmed.0040061","volume":"4","author":"I Boutron","year":"2007","unstructured":"Boutron I, Guittet L, Estellat C, Moher D, Hr\u00f3bjartsson A, Ravaud P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4(2):e61.","journal-title":"PLoS Med"},{"issue":"6","key":"4681_CR60","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/ije\/dyy213","volume":"47","author":"RS McCann","year":"2018","unstructured":"McCann RS, van den Berg H, Takken W, Chetwynd AG, Giorgi E, Terlouw DJ, et al. Reducing contamination risk in cluster-randomized infectious disease-intervention trials. Int J Epidemiol. 2018;47(6):2015\u201324.","journal-title":"Int J Epidemiol"},{"key":"4681_CR61","unstructured":"World Health Organization: Digital health. 2023. Available from: https:\/\/www.who.int\/health-topics\/digital-health#tab=tab_2. Cited 23 October 2023"},{"key":"4681_CR62","unstructured":"ICMJE: Recommendations for the conduct, reporting, editing, andpublication of scholarly work in medical journals. 2024. Available from: https:\/\/icmje.org\/icmje-recommendations.pdf. Cited 29 October 2023"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04681-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:02:19Z","timestamp":1779080539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04681-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4681"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04681-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study will adhere to the Declaration of Helsinki of 1975 and the Medical Research Involving Human Subjects Act. The study protocol underwent review and approval by the Ethics Committee of Nagoya City University Graduate School of Medicine and four other centers (46\u201323-0003). Participants will receive and sign an online informed consent form before participating. The full consent form, which describes in detail the study procedures, risks, and participants\u2019 rights, is available in the Supplementary material. Important protocol modifications will be notified to the collaborating facility directors and participants after Ethics Committee approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Ethics Committee determined that consent for publication was not required, as no individual personal data are included in this protocol manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}